Navigation Links
Naglazyme Approved by Brazil's National Health Surveillance Agency
Date:2/3/2009

nditions. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which was developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase 1 clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the continued clinical development and commercialization of Naglazyme and BioMarin's other products and product candidates and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: our success in the continued commercialization of Naglazyme; the content and timing of decisions by the U.S. Food and Drug Administration, the European Commission and other regulatory authorities concerning each of the described products and product candidates
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Naglazyme Approved by Japanese Ministry of Health
2. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
3. Watsons GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
4. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
5. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
6. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
7. Pharmaxis Aridol Approved for Sale in Switzerland
8. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
9. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
10. ARIUS sale approved by shareholders
11. Video: Keppra XR(TM) Approved in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (NASDAQ: ONCE ) announced today that members ... and Company Health Care Conference on Wednesday, March 4, ... Copley Place. To access the live webcast ... please visit the "Upcoming Events" section within the "News ... www.sparktx.com .  A replay of the webcast will ...
(Date:2/26/2015)... Feb. 26, 2015 Caris Life Sciences® ... the 2015 Genitourinary Cancers Symposium in ... utility of tumor profiling. Both studies utilized Caris ... service, to identify biomarkers that shed light on ... small cell bladder cancer (SCBC). ...
(Date:2/25/2015)... Calif. , Feb. 25, 2015 ... nootropic drink, is featured in this week,s Power ... cnbc.com/id/102454724 , to discuss the company,s traction and ... offering through the crowd funding site CircleUp. ... novel products that are validated by neurotechnology, while ...
(Date:2/25/2015)... 2015 Market Publishers Ltd is happy ... by 9Dimen Research have been recently uploaded to its ... Market Research Report . This research report provides wealth ... the world adhesive mortar industry as well as includes ... major regional markets. It focuses on the main regions ...
Breaking Biology Technology:Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 3New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 4
... MADISON The push to amend the Wisconsin Constitution to ... in one of the states longest books the need ... a Taxpayer Bill of Rights is a best-seller or a ... Wisconsin changes how government raises and spends money. , ,Republican ...
... Information Networks Corp . President Paul Shain spoke ... of Accelerate Madisons monthly meeting. According to Shain, Berbees unique ... of the dot-com era as other information technology-focused companies failed. ... company was founded on the dogma of creating an environment ...
... who signs the paychecks in your organization. Most of us ... to whom. We might even know one or two board ... you much about who your IT staff is really working ... members become moles in your organization as they further the ...
Cached Biology Technology:Debate over Taxpayer Bill of Rights shows need for true tax reform 2Berbees success is based on companys history and culture 2Berbees success is based on companys history and culture 3Berbees success is based on companys history and culture 4Who does your IT staff work for? 2Who does your IT staff work for? 3
(Date:2/5/2015)... Jan. 28, 2015 Research and Markets ... of the "Global Biometrics Market (2014-2020): Market ... Countries " report to their offering. , ... Asia-Pacific is anticipated to overtake ... to increasing government spending towards IT security, government ...
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition ... report to their offering. , The primary ... is who she/he is claiming to be, and for this ... physical characteristics, such as fingerprint, hand or palm print, iris, ...
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
Breaking Biology News(10 mins):Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... MD The Federation of American Societies for ... for the Science Research Conference (SRC): Mechanism and ... FASEB Science Research Conference on Mechanism and Regulation ... in Saxton Rivers, VT. The "Vermont Transcription Meeting," ...
... Institute (UPCI) researchers have uncovered a technique to halt the growth ... new anti-cancer therapy. When deprived of a key protein, ... in the cover story of the February issue of the ... by a grant from the National Institutes of Health. ...
... of antibody-producing cells, a finding that could lead to ... of control, such as myeloma and chronic immune disorders. ... critical for keeping this vital immune cell population alive ... Hall Institute. Associate Professor David Tarlinton, Dr Victor Peperzak ...
Cached Biology News:Pitt researchers reveal mechanism to halt cancer cell growth, discover potential therapy 2Immune cell 'survival' gene key to better myeloma treatments 2